×
Program Committee
-
Nancy Dreyer, PhD, MPH, FISPE Founder
Dreyer Strategies LLC, United States -
Steven A. Anderson, PhD Director, Office of Biostatistics and Epidemiology, CBER
FDA, United States -
Dorothee Bartels, PhD, MSc Chief Digital Officer
Aetion, Germany -
Brian Bradbury, DrSc, MA Vice President, Center for Observational Research
Amgen, United States -
Paul M. Coplan, DrSc, MBA, MSc, FISPE VP, Medical Device Epidemiology & Real-World Data Analytics
Johnson & Johnson, United States -
Marni Hall, PhD, MPH Vice President and General Manager, Global Regulatory Science and Strategy
IQVIA, United States -
James Harnett, PharmD, MS Executive Director, Health Economics and Outcomes Research
Regeneron Pharmaceuticals, Inc. , United States -
Jingyu (Julia) Luan, PhD Executive Regulatory Science Director, BioPharmaceuticals R&D
AstraZeneca, United States -
David Martin, MD, MPH Vice President, Head, PCO Center of Excellence
Novartis, United States -
Robert Reynolds, DrSc, MSc, FISPE Vice President, Epidemiology & Patient-Centered Outcomes, VEO
GSK, United States -
Debra Schaumberg, DrSc, MPH Vice President and Global Head, Startegic Development Consulting Chair
Evidera | PPD, United States -
Mark Stewart, PhD Vice President, Science Policy
Friends of Cancer Research, United States
Have an account?